News

Pharmaceutical Technology7h
ASCO25: Roche’s Itovebi combo reduces risk of death in breast cancer by 33%
In combination with Pfizer’s CDK4/6 inhibitor Ibrance (palbociclib) and anti-oestrogen drug Faslodex (fulvestrant), Itovebi ...
Pharmaceutical Technology7h
Genentech to onshore US manufacturing amid rising drug pricing tensions
Genentech has announced an investment exceeding $700m to establish its first East Coast manufacturing facility in North ...
Pharmaceutical Technology13h
FDA approves GSK’s Nucala to treat COPD
GSK has received approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab).
Pharmaceutical Technology14h
Aptar Digital to use AstraZeneca’s AI algorithms for CKD detection
Aptar Digital Health has signed a licensing agreement with AstraZeneca for detecting CKD using the latter’s AI-driven ...
Pharmaceutical Technology11h
Obesity therapies and the multi-indication momentum: how industry is responding
The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...
Pharmaceutical Technology12h
Medicaid on a spit after Republicans’ budget bill passes House by single vote
The Trump administration’s budget reconciliation bill has passed the US House of Representatives by a wafer-thin single-vote ...
Pharmaceutical Technology12h
Bayer’s Eylea set for longer treatment intervals to challenge Roche’s Vabysmo
An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...
Pharmaceutical Technology12h
Introducing the Pharmaceutical Technology Excellence Awards 2025
The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are ...